Ms Bowler faced four sets of charges, each of which contained sub-charges, summarised as follows:
Despite being served with the Notice of Inquiry, Ms Bowler decided not to attend the hearing due to ill-health but was represented by a counsel and solicitors.
The Committee did not find that Ms Bowler was medically unfit to attend on the basis of the medical evidence before it.
The Committee also concluded that it was in the public interest and interests of Ms Bowler to proceed with the hearing in her absence so that it could be concluded in a timely manner.
Ms Bowler’s counsel applied for parts of the hearing to be heard in private on health grounds, which was approved by the Committee.
It was also determined that any parts in the Committee’s decision or hearing that referred to Ms Bowler’s health would be redacted.
At the outset of the hearing, Ms Bowler’s counsel made admissions to five of the sub-charges which the Committee therefore found proven.
She also made some partial admissions in relations to a further 11 sub-charges.
After hearing a wide range of evidence, both written and oral, from Ms Bowler, the College, from clients and from an expert witness, the Committee found all charges proved except for four sub-charges.
On deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account.
In mitigation:
In all, the Committee decided that the seriousness of the misconduct meant that a sanction was necessary to meet the public interest.
When deciding on whether to issue a reprimand with or without a warning, the Committee once again decided that the misconduct was too serious to allow for this.
It also decided that a reprimand and/or warning was not sufficient to protect animals and the wider public interest.
It then went onto consider whether a sanction of ‘suspension’ was sufficient but noted that it did not have enough evidence to show that Ms Bowler had shown significant insight to continue to practise unrestricted in the future.
The Committee eventually concluded that Ms Bowler’s conduct was incompatible with remaining on the Register.
Neil Slater, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee decided that the broad range of Ms Bowler’s misconduct which had spanned three years and eight months and involving injury or risk of injury to 18 animals, was incompatible with remaining on the Register and the public interest required removal from the Register even when all of Ms Bowler’s mitigation was taken into account.
“The Committee decided that it did not have sufficient evidence overall on Ms Bowler’s insight, current competence and future risk to persuade it that the lesser sanction of suspension was appropriate in this case.
“Although Ms Bowler had shown some insight, the Committee decided that she would need to have provided detailed evidence about her current practice before it could decide that she no longer represented a risk to animals in the future.
“The Committee therefore concluded that ‘removal from the Register’ was the appropriate and proportionate sanction because there had been a serious departure from professional standards, a reckless disregard for professional standards, multiple cases involving harm or risk of harm to animals and because, in Ms Bowler’s absence, it had been difficult to unravel whether she had an attitudinal problem.
“These were all factors in the Disciplinary Committee Sanctions Guidance that indicated that a sanction of removal was the appropriate sanction and, in the Committee’s decision, removal from the Register was the only sanction which would meet the public interest.
"It concluded that a lesser sanction would undermine public confidence in the profession and in the regulatory process.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetNurse.co.uk product briefing: https://www.vetnurse.co.uk/nursing/m/veterinary-product-briefings/156724
References
The webinar is being presented by Cassie Woods (RVN Cons) CertNCS, Equine Nurse and Partner at Lower House Equine Clinic in Shropshire.
Cassie has a degree in bio-veterinary science and many years experience working in equine and small animal practice.
She regularly lectures for BVNA and BEVA. She is a member of the BEVA equine nurse committee and works closely with the BEVA Trust.
Cassie will share insights and practical strategies to strengthen biosecurity for both clinic and ambulatory teams, and will offer advice and guidance for helping clients to improve their own biosecurity measures.
She also hopes to further raise awareness of the vital roles equine nurses play in practice, promote and develop the role of the equine ambulatory nurse and improve training for equine veterinary grooms and technicians.
Horiba's Veterinary specialists will also be available to answer veterinary diagnostics-related questions and share information about the range of pathogen tests the company offers.
https://horiba.link/register-143bbc
Photo: www.depositphotos.com
Tim, who is Managing Partner of Larkmead Vets and also a Director at the independent veterinary community XLVets, graduated from Liverpool Vet School in 1994 and joined Larkmead Vets in 1998.
He said: “I grew up in the South Yorkshire coalfields and worked in a city centre small animal practice in Wakefield before relocating to Oxfordshire to develop the small animal department of a mixed practice.
"First-opinion veterinary practice has been my life since starting cleaning kennels aged 12.
“I am passionate that whilst what we do is work with animals, how we do it is by working with people: our colleagues and the owners who entrust their animals to our care.
"As a first-opinion vet and practice owner I have had the privilege of growing and developing my practice (team and facilities) to meet the changing needs of our local community.
“At a time of great change for the veterinary profession, with the tantalising hope for a new Veterinary Surgeons Act set against the backdrop of the Competition and Markets Authority’s market investigation of the veterinary sector, it is an opportunity to bring this experience to the heart of our College.
“It was an unexpected honour to be elected to the position of JVP and I thank my colleagues on Council for entrusting the role to me.
"I also reflect on my initial university application which saw a clean sweep of rejections and hope that this can inspire others from the grass roots of our profession to get involved in shaping the future.”
Council also voted to confirm Professor Tim Parkin as RCVS President, Linda Belton as Senior Vice-President and reconfirmed Tshidi Gardiner as Treasurer (subject to her re-election), all effective from July.
Tim will take up his post at the College's AGM in July.
Nutramega contains omega-3 fatty acids, specifically EPA and DHA, which the company says are critical for the overall health of animals, with many health benefits, including joints & mobility, skin & coat, heart health, the kidneys and brain health.
Nutramega comes in two sizes, 100ml and 200ml, with prices starting from £20.00.
Pet Ready LifeStages are health chews designed to provide daily support for puppies, adult dogs and senior dogs.
Each LifeStage product comes in 30 and 90 chew packets and prices range from £19.99 to £34.99.
www.nutravet.co.u
The survey is part of an initiative to develop a 'roadmap' for what needs to happen to support veterinary teams to deliver contextualised care and shared decision-making.
The survey will be used alongside interviews with people in a range of roles in the veterinary sector, including veterinary receptionists and practice managers, to gather insights about what makes it easier or more difficult to practise contextualised care and what could help support its delivery.
Pet owners will also be surveyed and invited to focus groups to understand what matters most to them when making decisions about their pets’ health, and what would help them to feel supported to decide the veterinary care that is right for them and their pet.
Sally Everitt, Clinical Lead – Evidence at RCVS Knowledge, said: “Although the term contextualised care is now being widely used, and a requirement to practise contextualised care is included in the RCVS Guidance for veterinary surgeons and veterinary nurses, there is little information available on how contextualised care is most effectively delivered in practice.
"Our research aims to address a gap in the evidence about what the barriers and enablers are and what needs to change to support veterinary teams to deliver contextualised care.”
The survey is open to veterinary surgeons currently in clinical practice in the UK working with dogs and cats.
The survey can be accessed here until 17th April 2025: https://survey.alchemer.eu/s3/90806393/rcvskresearchprofessionals
CVS says it believes the phone-based resource is a first in the profession.
It contains the ‘kennel side’ veterinary guidelines, notes and charts that clinicians would need to refer to in day-to-day companion animal practice.
It also includes clinical guidelines, anaesthesia, diagnostic imaging, dentistry and toxicology sections, along with an antibiotic guide.
CVS says it hopes the breadth of information in the MiGuide will improve and speed clinical decision-making, making recommendations to clients easier - and ultimately improving patient outcomes.
The hub is the brainchild of Alan Johnson, Regional Clinical Lead at CVS.
He said: “Every day in practice is different.
"You regularly have to do things you have not done for a while.
"So you either have to recall how to do them or spend time looking them up.
"This can be especially difficult when you are looking for very specific information which is buried in a textbook.
“I wanted to consolidate the key clinical information that every colleague needs every day - all in one location.
"I wanted to make information easy to find at a few clicks.
"And I wanted vets and nurses to have this information in their pocket – to refer to if the need arose.
“We hope our new portal is helpful and supportive – and makes daily practice smoother for our vets and nurses.
"And we hope that it improves and speeds up clinical decision-making to provide the best care for our patients.”
LacriProtect is designed to increase the depth of the tear film in the management of dry eye, during anaesthesia, or in case of irritation.
It contains a carbomer-based formula in individual, resealable single-use pipettes, so that each application is hygienic and free from cross-contamination.
This, says Samaxia, is particularly useful in clinical settings.
Lacri+ contains 0.4% cross-linked sodium hyaluronate and urea, and is designed to hydrate, lubricate and protect the ocular surface.
It comes in a multi-dispense bottle with a tip-seal mechanism and multilayer filtration to ensure sterility and give a shelf life of three months after opening.
https://www.samaxia.com
The report comes on the back of a survey by the association which found that 93% of vets say sustainability is important to them.
The BVA says the report aims to break down the challenge that both teams and individuals face in working towards net zero emissions.
It explains the impact of climate change, what the veterinary profession’s role is in tackling it and why the BVA thinks it is so important that the profession plays its part.
The report also includes resources and showcases the ways real veterinary workplaces are taking action to reduce their impact on the environment.
British Veterinary Association Senior Vice President Anna Judson said: “Many veterinary professionals have long been concerned about the impact the sector is having on the environment, and many are already taking action to mitigate this.
"However, there is still more work to do.
"Our vision is that by 2050 the profession will have adapted to support the UK’s net zero targets; is trusted on mitigating its own carbon footprint; and is a leading advocate for environmental sustainability.
"This new report is providing vet teams with the tools and the inspiration to do their bit, because small changes add-up to make a big difference.”
There'll be a session on the subject at the London Vet Show this year, chaired by Anna Judson, with panelists Ed Bailey, Clinical Director and Sustainability Lead at George Farm Vets, Laura Binnie, Sustainability Lead at Paragon Veterinary Group and James Bevan, Planetary Health Senior Teaching Fellow Public Health Registrar, University of Southampton.
"Practice what you preach: Reaching net zero is a team effort" will be held at 10.45am - 11.45am on 14 November in the BVA Congress Theatre.
www.bva.co.uk/net-zero-report
Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.
The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.
The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.
The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.
The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.
The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.
The Committee found all elements of the charges proven.
The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.
These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.
Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.
The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.
In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.
"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.
"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”
The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.
It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.
It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.
Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.
Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.
"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.
“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.
"The respondent had ample opportunities for reflection before resolving to act as he did.
"This places his acts of dishonesty in the most serious category.
“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.
"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”
www.rcvs.org.uk/disciplinary
IVC's existing Pet Health Club includes vaccinations, flea and worm treatments, microchipping, health checks and a variety of discounts.
IVC says the new tier, Pet Health Club Plus, has been introduced to encourage owners to bring their pet in early, meaning problems can be diagnosed more quickly and therefore improve the welfare outcome of the pet.
It is also designed to support owners by spreading the cost of their pet’s healthcare.
25,000 pet owners have already joined Pet Health Club Plus, which costs £27.99 for cats and £29.99 for dogs, and it is now being pushed with a national TV advertising campaign which will run till the end of the year.
Paragon’s gardens feature bee and insect hotels, bird feeders, bat boxes and robin hides, plants for pollinators and long grass to suit hedgehogs.
The garden at Dalston has a bog garden and pond.
Children from the local primary school visit to plant trees and scatter wildflower seeds.
Paragon’s most ambitious project is at Newbiggin where, with the help of a grant from Forestry England, it is planting a three-hectare native broadleaf woodland, reinstating hedgerows and incorporating a wildflower meadow.
Gardeners’ World’s Frances Tophill presented the framed certificate and trophy at the Britain in Bloom Awards at Old Trafford Stadium, Manchester.
Laura Binnie, small animal vet and sustainability lead at Paragon, said: “When we set out to create wellbeing gardens for our staff to enjoy, and to do it as sustainably as we could, we never thought it would go this far.”
“In the veterinary profession, we’re at that unique intersection where people, planet and animals come together.
“We feel a responsibility to do something for the community, for nature and for our clients and staff, and to lessen our impact on the climate crisis.”
https://www.paragonvet.com
The group was set up in 2019 by veterinary students Stephanie Stapleton and Lavinia Economu, to break down barriers and promote veterinary careers to young people, in part by becoming the role models they wished they’d had in school.
It also aims to correct misconceptions about what vets do, the pathway to becoming a vet and the various job options available in animal-related careers.
Over the years, Animal Aspirations has evolved to provide positive role models and practical advice to diverse students of all ages across the country, with a focus on supporting those from an ethnic minority or on Free School Meals through its school workshops.
It has expanded from nine students at the RVC to a team of 83 students.
The organisation also now has a presence across several leading institutions, including the University of Cambridge, the University of Surrey, Harper Adams University, Keele University and the University of Central Lancashire.
Lavinia said: “I’ve always lived and gone to school in Greater London, and so I was used to being surrounded by people from all backgrounds and walks of life.
"Once I started my veterinary degree, this was no longer the case, as few students came from diverse or ethnic minority backgrounds.
"This pattern seemed to be the same in all vet schools and even the veterinary profession, but there were very few if any, initiatives to address it.
“During my intercalated year at the RVC, I was lucky enough to meet Stephanie Stapleton, another vet student who also shared my passion for increasing diversity in veterinary medicine.
"She introduced me to the Widening Participation team at the RVC, and together, we recruited an amazing group of vet students, and Animal Aspirations was born.
“I truly think this is one of the best professions to be in, and I’d like to see it become more accessible and inclusive to all young people, no matter their background.”
Lharanya Somasundaram, President of Animal Aspirations, said: “It has been incredible to see the impact of our work, how misconceptions that once served as barriers are being challenged, and how young people feel more empowered to pursue their dreams.
“However, there is still much work to be done. The goal is to create such a diverse and inclusive environment that it can sustain itself and the support we provide is the norm. This only becomes possible when everyone, regardless of experience, position or background, is committed to championing diversity.
“We should all be thinking about how we can make ourselves and our workplaces more inclusive.
"With these combined efforts, we get closer to a profession where everyone feels as though they truly belong.”
https://www.animalaspirations.com
George Philippus Hauptfleisch faced three charges in relation to allegations of clinical failings surrounding three patients:
The first charge surrounded the allegations that in 2018, Mr Hauptfleisch failed to provide appropriate and adequate care to Steel, a Cane Corso Mastiff, in that he performed surgery outside of his competence, failed to offer a reasonable range of treatment options as alternatives, failed to make adequate enquiries about the possibility of a referral to a specialist, failed to obtain informed consent to the surgery, and failed to maintain adequate clinical records.
The second charge, in relation to a German Shepherd, alleged that in 2019, Mr Hauptfleisch failed to provide appropriate and adequate care when he undertook surgery which was outside of his competence and failed to undertake the surgery to an adequate standard, failed to note sufficient details to show that informed consent for the surgery had been obtained, and failed to maintain adequate clinical records.
The third charge, in relation to a Retriever, alleged that Mr Hauptfleisch failed to provide appropriate and adequate care with regards to surgery he performed when it was outside of his competence, failed to undertake the surgery to an adequate standard, failed to note sufficient details that showed informed consent had been obtained, and failed to maintain adequate clinical records.
Prior to the hearing, Mr Hauptfleisch made an application to the Committee to dispose of the matter by way of adjournment for an indefinite period, against his undertakings to request the Registrar to remove him from the Register, and never to seek restoration to the Register.
In deciding whether to grant the application, the Committee took into account a number of factors.
These included the fact that Mr Hauptfliesch had, in December 2021, returned to South Africa, after a career of over 32 years in the UK, and now resides there permanently, the fact that he has no intention of moving back to the UK, and that he had not practised as a veterinary surgeon since the day he left.
He had also removed himself from the equivalent register in South Africa and the Committee noted that the RCVS would inform the South African Veterinary Council of the outcome of these proceedings.
The Committee also noted that there were no previous disciplinary findings against him, that Mr Hauptfleisch now spends the majority of his time undertaking charitable activities, including running a mentoring programme for young people, and, that he expressed deep regret for anything which he did or did not do which failed to protect the welfare of animals or caused upset to his clients and fellow members of the profession.
Mr Hauptfleisch also drew attention to the fact that the charges did not allege dishonesty and that the reputation of the profession would be upheld as Mr Hauptfleisch would no longer practise as a veterinary surgeon and would not return to practise.
Therefore, it would not be proportionate, nor in the public interest, for there to be a lengthy contested hearing resulting in substantial costs for both the RCVS and for Mr Hauptfleisch.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “Taking into account the removal from the Register and the respondent’s undertaking never to apply for restoration, in conjunction with all of the circumstances, the Committee was satisfied that allowing the application would be sufficient to uphold the public interest, confidence in the profession and the RCVS as a regulator, and protect the welfare of animals.
“As a result of all the factors set out, and taking into account the nature of the charges which relate to the alleged inadequate standard of clinical practice, the Committee decided that this is not a case in which there were wider issues relevant to the profession at large, such as those which had public policy implications and which required full consideration at a hearing.
“The Committee was satisfied that neither the public interest nor the welfare of animals demands that there be a full hearing in this case.
“Taking into account proportionality and weighing in the balance all the circumstances of the case, the interests of justice, the public interest, the need to uphold proper standards of conduct and performance, and the need to protect the welfare of animals, the Committee decided to grant the respondent’s application.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
Polypropylene or plastic-based wipes, which have been industry standard due to their reliable nature and compatibility with biocidal active materials, are due to be banned in the UK, because they take up to 100 years to break down.
Byotrol says its new wipes are made using a plastic-free 100% biodegradable substrate that deteriorates 3 months after disposal.
The company adds that the new wipes are proven to destroy bacteria, yeast, enveloped viruses, and fungi on non-porous surfaces and are effective against animal-specific pathogens such as: Brucella canis, Streptococcus equi, Staphylococcus aureus, Salmonella typhimurium, Bordetella bronchiseptica, Coronaviruses, Feline Immunodeficiency Virus (FIV), and Microsporum canis and Trichophyton mentagrophytes
Jane Kiely, Head of Marketing at Byotrol said: “Launching the Anigene Professional Surface Disinfectant Wipes is the final step in removing plastic wet wipes from our portfolio and a significant milestone in Byotrol’s sustainability journey.
"We are proud to be at the forefront of sustainability in the veterinary industry, offering an effective and regulatory-compliant product range that meets the needs of our customers”
Byotrol will be on Stand F18 at the London Vet Show.
https://byotrol.com
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
Reference
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423
The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
Bethany said: “I have always wanted to provide the best care for my patients and support my team in their work too.
This qualification was the next step in that and thinking of my patients and peers was really the inspiration for me.
“At work I received invaluable help to get my VTS and was able to access Linnaeus’ enhanced support package for my studying.
"It included mentors and help from nurses in the central support team along with study time, extra CPD allowances and networking.
“It was great to work alongside others aiming for the same thing, and to have the support from my employer.”
She added: “Having a better understanding of anaesthesia allowed me to better support patients through procedures and nurse them.”
The qualification took around two years to complete, with hours of training, work and exams.
Bethany added: “To even begin the application process, you must have worked in the discipline for five years, have 40 hours of CPD in the speciality and had two letters of recommendation from a specialist.
“The qualification is two years, with a casebook to complete, four case reports and two exams.
"It’s been hard work but it’s definitely worth it.”
To mark the end of his presidential year at BSAVA, Julian will be strapped to the top of a vintage biplane while dressed in a full feline (Cheshire Cat) costume, to support the research that BSAVA PetSavers funds, to improve the health and wellbeing of pets across the UK.
BSAVA PetSavers is one of the UK’s few funding bodies focused solely on clinical research into diseases affecting companion animals.
To date, it has invested more than £2.7 million in vital studies addressing conditions such as cancer, heart disease, neurological and joint disorders, gastrointestinal issues.
Julian said: "Every day, vets face the heart-wrenching task of managing the distress and pain our pets suffer due to disease or poor health.
"With your support, we can ensure that they have access to the latest knowledge and resources needed to provide the best care possible.
“The need for advanced research is more pressing than ever and our pets deserve every chance at a healthy life.
"If dressing up as a cat and flying on the wing of a plane makes people take notice of the vital need for pet health research, then it will be worth it.”
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “No one has ever been quite so daring in their fundraising efforts for us, so we are thrilled that Julian has decided to take this on to raise awareness and funds for BSAVA PetSavers.
“For every grant application that we fund, at least two or more are declined due to lack of funds. Fundraising events like this helps to land more funding in the hands of researchers who make a real difference in the veterinary community and directly impact the lives of countless pets and their families.”
Julian’s wing walk is on the 29th May and his target is to fundraise £1,000.
https://www.justgiving.com/page/julian-hoad-2